1.Estimated glomerular filtration rate in alcohol use disorder people
Erdenebat N ; Khorolgarav A ; Narantsatsral D ; Zoljargal S ; Oyunchimeg Ch
Diagnosis 2024;111(4):42-46
Background:
The purpose of this study is to evaluate serum creatinine as a marker of estimated glomerular filtration rate (eGFR) in alcohol use disorder people, and to determine correlation between mean arterial pressure (MAP) and eGFR in chronic kidney disease classification level.
Methods:
In this study, 99 people were examined between January 2024 to November 2024. We measured serum
creatinine based GFR using the Cockroft Gault formula. Results were analyzed SPSS.
Result:
The mean subject age was 48.2±9.9 years, male: female ratio was 5:1. Mean arterial pressure was 103±13.5 mmHg, eGFR 95.5±28.8 ml/min/1.73m2, and mean arterial pressure was significantly correlated with estimated glomerular filtration rate (P<0.05) and no difference between male and female recipients.
Conclusion
According to our research, one of the optimal methods for assessing kidney function is the creatinine-based CKD calculation method, and excessive alcohol consumption is a risk factor for chronic kidney disease, as well as one of the main causes of complication and mortality in cardiovascular disease.
2.Alloxan Monohydrate-Аар Өдөөгдсөн Чихрийн Шижингийн Эмгэг Загварт Цульхир (Agriophyllum Pungens)-Ын Бэлдмэлийн Үзүүлэх Нөлөөг Судалсан Дүн
Oyunchimeg N ; Ariunaa Z ; Tsetsgee D ; Chimedragchaa Ch ; Mend-Amar B
Journal of Oriental Medicine 2014;6(1):19-24
Objective: In this study it was aimed to demonstrate the hypolipidemic and
hypoglycemic potentials of Agrypum extract on alloxan-induced diabetic rats.
Materials and methods: Eighteen male Wistar rats of weights between 140 g were
used for the study and divided into three groups of six rats each. The rats of the
non-diabetic control group were given 1 ml of distilled water daily. Two other groups
induced with diabetes using alloxan by a single dose administration of 120 mg/kg
body weight (BW); one of these diabetic rat groups were treated with seeds of this
plant (Agrypum) extract daily at 1.5 ml/100 g BW for 4 weeks while the other group
was left untreated. Blood samples were collected and total cholesterol (TC),
triglyceride (TG), high-density lipoprotein (HDL), lowdensity lipoprotein (LDL) and
glucose levels were assayed. Results: After four weeks of treatment, data indicated
significant reductions in BW, blood glucose, TG, TC and LDL levels of diabetic rats
treated with seeds of this plant (Agrypum) extract compared to the non-treated
group. The treated diabetic rats also indicated significantly higher HDL levels
compared to the non-treated group. Conclusion: Treatment of diabetic rats with the
seeds of this plant (Agrypum) extract lowered blood glucose, TG, TC and LDL levels
and increased the HDL level. This shows that the extract has both hypoglycemic
and hypolipidemic effects.